Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb;9(2):111-121.
doi: 10.1016/j.trecan.2022.10.009. Epub 2022 Nov 12.

Weaponizing natural killer cells for solid cancer immunotherapy

Affiliations
Review

Weaponizing natural killer cells for solid cancer immunotherapy

Joshua K M Wong et al. Trends Cancer. 2023 Feb.

Abstract

Enhancing natural killer (NK) cell-based innate immunity has become a promising strategy for immunotherapy against hard-to-cure solid cancers. Monoclonal antibody (mAb) therapy has been used to activate NK-cell-mediated antibody-dependent cellular cytotoxicity (ADCC) towards solid cancers. Cancer cells, however, can subvert immunosurveillance using multiple immunosuppressive mechanisms, which may hamper NK cell ADCC. Mechanisms to safely enhance ADCC by NK cells, such as utilizing temporary inhibition of receptor endocytosis to increase antibody presentation from target to effector cells can now be used to enhance NK-cell-mediated ADCC against solid tumors. This review summarizes and discusses the recent advances in the field and highlights current and potential future use of immunotherapies to maximize the therapeutic efficacy of innate anticancer immunity.

Keywords: NK cells; antibody therapeutics; antibody-dependent cellular cytotoxicity; solid tumors; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests No interests are declared.

Publication types

MeSH terms

Substances

LinkOut - more resources